Engineering Polymeric Prodrug Nanoplatform for Vaccination Immunotherapy of Cancer | |
Zhou, Lei3,4,5; Hou, Bo4,5; Wang, Dangge4,5; Sun, Fang4,5; Song, Rundi4,5; Shao, Qian1; Wang, Hao3; Yu, Haijun2,4,5; Li, Yaping2,4,5 | |
刊名 | NANO LETTERS |
2020-06-10 | |
卷号 | 20期号:6页码:4393-4402 |
关键词 | Polymeric prodrug Neoantigen Adaptive immune response Personalized immunotherapy Nanoparticles |
ISSN号 | 1530-6984 |
DOI | 10.1021/acs.nanolett.0c01140 |
通讯作者 | Yu, Haijun(hjyu@simm.ac.cn) ; Li, Yaping(ypli@simm.ac.cn) |
英文摘要 | Neoantigen-based cancer vaccines are promising for boosting cytotoxic T lymphocyte (CTL) responses. However, the therapeutic effect of cancer vaccines is severely blunted by functional suppression of the dendritic cells (DCs). Herein, we demonstrated an acid-responsive polymeric nanovaccine for activating the stimulator of interferon genes (STING) pathway and improving cancer immunotherapy. The nanovaccines were fabricated by integrating an acid-activatable polymeric conjugate of the STING agonist and neoantigen into one single nanoplatform. The nanovaccines efficiently accumulated at the lymph nodes for promoting DC uptake and facilitating cytosol release of the neoantigens. Meanwhile, the STING agonist activated the STING pathway in the DCs to elicit interferon-beta secretion and to boost T-cell priming with the neoantigen. The nanovaccine dramatically inhibited tumor growth and occurrence of B16-OVA melanoma and 4T1 breast tumors in immunocompetent mouse models. Combination immunotherapy with the nanovaccines and anti-PD-L1 antibody demonstrated further improved antitumor efficacy in a 4T1 breast tumor model. |
资助项目 | National Natural Science Foundation of China[51873228] ; National Natural Science Foundation of China[31671024] ; National Natural Science Foundation of China[81521005] ; Natural Science Foundation of Shandong Province[ZR2019LZL020] ; State Key Laboratory of Drug Research[SIMM2004KF-04] |
WOS关键词 | INNATE IMMUNE RECOGNITION ; DENDRITIC CELLS ; POTENT ; DELIVERY ; MICROENVIRONMENT ; NANOPARTICLES ; MICELLEPLEXES ; INTERFERONS ; NANOVACCINE ; ACTIVATION |
WOS研究方向 | Chemistry ; Science & Technology - Other Topics ; Materials Science ; Physics |
语种 | 英语 |
出版者 | AMER CHEMICAL SOC |
WOS记录号 | WOS:000541691200043 |
内容类型 | 期刊论文 |
源URL | [http://119.78.100.183/handle/2S10ELR8/291801] |
专题 | 中国科学院上海药物研究所 |
通讯作者 | Yu, Haijun; Li, Yaping |
作者单位 | 1.Shandong Inst Canc Prevent & Treatment, Jinan 250117, Shandong, Peoples R China 2.Yantai Inst Mat Med, Yantai Key Lab Nanomedicole & Adv Preparat, Yantai 264000, Shandong, Peoples R China 3.China State Inst Pharmaceut Ind, Shanghai 201203, Peoples R China 4.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China 5.Chinese Acad Sci, Shanghai Inst Mat Med, Ctr Pharmaceut, Shanghai 201203, Peoples R China |
推荐引用方式 GB/T 7714 | Zhou, Lei,Hou, Bo,Wang, Dangge,et al. Engineering Polymeric Prodrug Nanoplatform for Vaccination Immunotherapy of Cancer[J]. NANO LETTERS,2020,20(6):4393-4402. |
APA | Zhou, Lei.,Hou, Bo.,Wang, Dangge.,Sun, Fang.,Song, Rundi.,...&Li, Yaping.(2020).Engineering Polymeric Prodrug Nanoplatform for Vaccination Immunotherapy of Cancer.NANO LETTERS,20(6),4393-4402. |
MLA | Zhou, Lei,et al."Engineering Polymeric Prodrug Nanoplatform for Vaccination Immunotherapy of Cancer".NANO LETTERS 20.6(2020):4393-4402. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论